Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.
<h4>Objective</h4>We aimed to determine the validity of two risk scores for patients with non-muscle invasive bladder cancer in different European settings, in patients with primary tumours.<h4>Methods</h4>We included 1,892 patients with primary stage Ta or T1 non-muscle inva...
Guardado en:
Autores principales: | Moniek M Vedder, Mirari Márquez, Esther W de Bekker-Grob, Malu L Calle, Lars Dyrskjøt, Manoils Kogevinas, Ulrika Segersten, Per-Uno Malmström, Ferran Algaba, Willemien Beukers, Torben F Ørntoft, Ellen Zwarthoff, Francisco X Real, Nuria Malats, Ewout W Steyerberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e15aba37e2e472c975b0a873df38b8b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The use of molecular analyses in voided urine for the assessment of patients with hematuria.
por: Willemien Beukers, et al.
Publicado: (2013) -
Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
por: Alberto Valdés, et al.
Publicado: (2021) -
Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.
por: Angela A G van Tilborg, et al.
Publicado: (2012) -
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
por: Iliana K Kerzeli, et al.
Publicado: (2021) -
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.
por: Richard D Riley, et al.
Publicado: (2013)